Endpoints News

Endpoints News

Disc Medicine's data in rare blood cancer		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T W Thu F

10 September, 2026

AI has stopped being a question and started being an answer. Remaking workforces, AI-derived molecules into the clinic, catching record capital against sharpening doubt. What does it mean for biopharma? Find out, join us.

news

Peer Review

Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

How past Endpoints 11 winners fared as the biotech industry rebounded

News Briefing

Disc Medicine's Phase 2 rare blood cancer data; Frazier adds to public fund

Sep 16

2:00 pm ET

Beyond ICD codes: Unlocking rare disease insights with genomics and claims-based data

sponsored by GeneDx

Sep 22

12:00 pm ET

The future of drug pricing: Medicare negotiation, MFN models & beyond

sponsored by ADVI

Oct 15

1:00 pm ET

Insights into Polycystic Kidney Disease: The Potential of Clinicogenomic Data

sponsored by Natera

Oct 20

11:00 am ET

Intelligent oversight and orchestration: How mission control is redefining R&D decision-making

sponsored by ZS

Oct 22

11:00 am ET

A new model for clinical research – Expanding community trial access

sponsored by Parexel

One night, one room: the founders, scientists and investors behind the Endpoints 11, together in Boston this September. Reserve your spot now and save with the early bird rate.

in case you missed it

1.

FDA suggests regulatory flexibility for assessing psychedelics

2.

FDA places partial hold on Biohaven's ion channel drug

3.

BridgeBio Oncology slides as it tightens the scope of its KRAS program

4.

Pharma investment in UK picks up after last year’s lull, trade group says

5.

Novo to disclose ‘next chapter’ at Sept. 15 employee event

6.

Anthropic says it blocked possible efforts to build biological weapons

Reynald Castaneda

.

Our very popular Peer Review column about people moves is back this week with a bumper edition. Grab a coffee and dive in!

.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com